These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 23580582)

  • 1. Reply to "Vancomycin-induced nephrotoxicity".
    van Hal SJ; Paterson DL; Lodise TP
    Antimicrob Agents Chemother; 2013 May; 57(5):2436. PubMed ID: 23580582
    [No Abstract]   [Full Text] [Related]  

  • 2. Vancomycin-induced nephrotoxicity.
    Gelfand MS; Cleveland KO
    Antimicrob Agents Chemother; 2013 May; 57(5):2435. PubMed ID: 23580581
    [No Abstract]   [Full Text] [Related]  

  • 3. Increasing vancomycin serum trough concentrations and incidence of nephrotoxicity.
    Pritchard L; Baker C; Leggett J; Sehdev P; Brown A; Bayley KB
    Am J Med; 2010 Dec; 123(12):1143-9. PubMed ID: 21183005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Nephrotoxicity of Vancomycin.
    Filippone EJ; Kraft WK; Farber JL
    Clin Pharmacol Ther; 2017 Sep; 102(3):459-469. PubMed ID: 28474732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vancomycin-associated nephrotoxicity: unintentional consequences of a loading dose?
    Flannery AH; Bachmeier H
    Crit Care Med; 2015 May; 43(5):e154. PubMed ID: 25876127
    [No Abstract]   [Full Text] [Related]  

  • 6. Risk factors for vancomycin nephrotoxicity: still a matter of debate*.
    Costa e Silva VT; Marçal LJ; Burdmann EA
    Crit Care Med; 2014 Dec; 42(12):2635-6. PubMed ID: 25402286
    [No Abstract]   [Full Text] [Related]  

  • 7. [Vancomycin nephrotoxicity: Frequency and mechanistic aspects].
    Luque Y; Mesnard L
    Nephrol Ther; 2018 Apr; 14 Suppl 1():S133-S138. PubMed ID: 29606259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systematic review and meta-analysis of vancomycin-induced nephrotoxicity associated with dosing schedules that maintain troughs between 15 and 20 milligrams per liter.
    van Hal SJ; Paterson DL; Lodise TP
    Antimicrob Agents Chemother; 2013 Feb; 57(2):734-44. PubMed ID: 23165462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The authors reply.
    Hanrahan TP; Harlow G; Dulhunty JM; Lipman J; Whitehouse T; Roberts JA
    Crit Care Med; 2015 May; 43(5):e154-5. PubMed ID: 25876128
    [No Abstract]   [Full Text] [Related]  

  • 10. Kidney biopsy findings in vancomycin-induced acute kidney injury: a pooled analysis.
    Bellos I; Pergialiotis V; Perrea DN
    Int Urol Nephrol; 2022 Jan; 54(1):137-148. PubMed ID: 33715061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Efficacy and nephrotoxicity of vancomycin in the treatment of Gram positive infections].
    Du B; Chen DC; Liu DW
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2003 Jan; 15(1):32-4. PubMed ID: 12852813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute kidney injury with combination vancomycin and piperacillin-tazobactam therapy in the ICU: A retrospective cohort study.
    O'Callaghan K; Hay K; Lavana J; McNamara JF
    Int J Antimicrob Agents; 2020 Jul; 56(1):106010. PubMed ID: 32413387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Quasi-Experiment To Study the Impact of Vancomycin Area under the Concentration-Time Curve-Guided Dosing on Vancomycin-Associated Nephrotoxicity.
    Finch NA; Zasowski EJ; Murray KP; Mynatt RP; Zhao JJ; Yost R; Pogue JM; Rybak MJ
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28923869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute kidney injury in a renal transplant recipient due to concomitant use of vancomycin and foscarnet.
    Kwan LP; Mok MM; Choy BY; Chan TM
    Nephrology (Carlton); 2017 Oct; 22(10):821-822. PubMed ID: 28921753
    [No Abstract]   [Full Text] [Related]  

  • 15. Eight unexpected cases of vancomycin associated acute kidney injury with contemporary dosing.
    O'Donnell JN; Ghossein C; Rhodes NJ; Peng J; Lertharakul T; Pham CK; Scheetz MH
    J Infect Chemother; 2017 May; 23(5):326-332. PubMed ID: 28109741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute kidney injury following the concurrent administration of antipseudomonal β-lactams and vancomycin: a network meta-analysis.
    Bellos I; Karageorgiou V; Pergialiotis V; Perrea DN
    Clin Microbiol Infect; 2020 Jun; 26(6):696-705. PubMed ID: 32222460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vancomycin nephrotoxicity may be overstated.
    Moffett BS; Kim S; Edwards M
    J Pediatr; 2011 May; 158(5):865-6; author reply 866. PubMed ID: 21324473
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of Rates of Nephrotoxicity Associated with Vancomycin in Combination with Piperacillin-Tazobactam Administered as an Extended versus Standard Infusion.
    Mousavi M; Zapolskaya T; Scipione MR; Louie E; Papadopoulos J; Dubrovskaya Y
    Pharmacotherapy; 2017 Mar; 37(3):379-385. PubMed ID: 28079263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A propensity-matched cohort study of vancomycin-associated nephrotoxicity in neonates.
    Constance JE; Balch AH; Stockmann C; Linakis MW; Korgenski EK; Roberts JK; Ward RM; Sherwin CM; Spigarelli MG
    Arch Dis Child Fetal Neonatal Ed; 2016 May; 101(3):F236-43. PubMed ID: 26400103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the incidence of vancomycin-induced nephrotoxicity in hospitalized patients with and without concomitant piperacillin-tazobactam.
    Burgess LD; Drew RH
    Pharmacotherapy; 2014 Jul; 34(7):670-6. PubMed ID: 24855041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.